NK012

NK012 · Nippon Kayaku Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for NK012, covering 2013-03-20 to 2015-02-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study of NK012 in Patients With Advanced, Metastatic Triple Negative Breast Cancer [Phase 2]